Format

Send to

Choose Destination
Annu Rev Med. 2006;57:381-402.

Cd4+Cd25+ regulatory T cells and their therapeutic potential.

Author information

1
Department of Pediatrics, Division of Neonatology, Stanford University School of Medicine, Stanford, California 94305, USA. drdrdr@stanford.edu

Abstract

The human immune system mounts specific responses to a vast array of antigens. Although this is clearly beneficial in fighting off harmful infections and cancerous cells, the system must be carefully controlled to ensure that normal self-antigens are not targeted. A recently characterized subset of T cells, identified by their cell surface expression of CD4 and CD25, is critical in regulating the function of other immune cells and preventing potentially harmful autoimmune responses. This article reviews what is currently known about these so-called regulatory T cells and discusses the therapeutic potential of these cells to modulate human immune-based diseases.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center